{"gene":"CACNG4","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1999,"finding":"CACNG4 was identified as a novel calcium channel gamma subunit gene located on chromosome 17, discovered through low-stringency genomic sequence analysis of regions syntenic to CACNG1 and CACNG2, establishing it as a member of the voltage-dependent Ca2+ channel gamma subunit gene family generated by tandem and chromosome duplication.","method":"Genomic sequence analysis, gene family identification by synteny","journal":"Genome research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene identification with genomic and evolutionary analysis, single study but clear experimental basis","pmids":["10613843"],"is_preprint":false},{"year":2005,"finding":"CACNG4 has seizure-suppressing activity in the corticothalamic circuit; homozygous Cacng4 knockout mice appear phenotypically normal, but combining the Cacng4 null allele with stargazer (Cacng2) mutant alleles exacerbates or induces absence seizures, demonstrating overlapping in vivo functions between CACNG4 and CACNG2 and restricting CACNG4 expression to the thalamus within the corticothalamic loop.","method":"Targeted gene disruption (knockout mouse), genetic epistasis (double mutant with Cacng2 alleles), seizure phenotype analysis, expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with defined phenotype, genetic epistasis with multiple Cacng2 alleles, expression localization, single rigorous study with multiple orthogonal approaches","pmids":["15677329"],"is_preprint":false},{"year":2002,"finding":"Chick CACNG4 is expressed in differentiating neurons and myoblasts during early development, with expression timing correlating precisely with the onset of neuronal differentiation in cranial and dorsal root ganglia and in the myotome, suggesting a role in modulating calcium channels during cellular differentiation.","method":"In situ hybridization, developmental expression analysis in chick embryo","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — expression characterization in developing tissue with functional inference, single lab, replicated across multiple tissue types","pmids":["11884034"],"is_preprint":false},{"year":2020,"finding":"CACNG4 promotes breast cancer metastasis by closing the channel pore to inhibit calcium influx, thereby altering calcium signaling through key survival and metastatic pathway genes including AKT2, HDAC3, RASA1, and PKCζ; CACNG4 overexpression alters cell motility in vitro, induces malignant transformation in 3D culture, and increases lung-specific metastasis in vivo.","method":"In vitro 2D and 3D assays, intracellular calcium influx assays, chick-CAM model, mouse metastasis model, gain/loss-of-function experiments, calcium channel blocker treatment","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo assays, direct calcium influx measurement, identification of downstream effectors, single lab with rigorous functional validation","pmids":["32062352"],"is_preprint":false},{"year":2022,"finding":"CACNG4 (CaVγ4) is required for pancreatic beta-cell maintenance of its differentiated state; Cacng4 knockout mice exhibit impaired fasting glucose and impaired glucose tolerance with blunted glucose-stimulated insulin secretion. CaVγ4 deletion reduces expression of the transcription factor MafA (on mRNA and protein levels), and CaMKII mediates the regulatory pathway linking CaVγ4 to MafA, as confirmed in mouse islets, human donor islets, and INS-1 832/13 cells.","method":"Cacng4 knockout mouse (in vivo glucose tolerance and insulin secretion assays), gene expression analysis (mRNA and protein), CaMKII pathway investigation, human islet RNA-seq validation, INS-1 cell line experiments","journal":"Biomedicines","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse with defined metabolic phenotype, mechanistic pathway (CaVγ4→CaMKII→MafA) validated in multiple model systems including human islets","pmids":["35453520"],"is_preprint":false},{"year":2025,"finding":"CUEDC1 directly modulates CACNG4 to enhance PI3K/AKT pathway activation, thereby facilitating glycolysis (via GLUT1 upregulation) and tumor growth in ER-positive breast cancer; this CUEDC1/CACNG4/PI3K axis was identified by RNA-seq, ChIP, and dual-luciferase reporter assays, with MAZ transcription factor upregulating CUEDC1 transcription.","method":"Dual-luciferase reporter assay, RNA-seq, chromatin immunoprecipitation (ChIP), metabolic glycolysis assays, mouse xenograft model, western blotting, qRT-PCR","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal molecular methods in single lab, mechanistic pathway defined with functional readouts in vitro and in vivo","pmids":["41315933"],"is_preprint":false},{"year":2023,"finding":"CACNG4 is upregulated in cancer stem cells (CSCs) of hepatocellular carcinoma (HCC); pharmacological inhibition of CACNG4 with amlodipine at low concentrations preferentially reduced CSC viability, markedly decreased tumorsphere formation, and reduced the ALDH1A1-high cell population, indicating a role for CACNG4 in maintaining the CSC state.","method":"FACS sorting of ALDH1A1-high cells, microarray gene expression analysis, tumorsphere formation assay, cytotoxicity assay with amlodipine (CACNG4 inhibitor)","journal":"Anticancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological inhibition with functional readouts, single lab, limited mechanistic depth but multiple functional assays","pmids":["37909988"],"is_preprint":false},{"year":2026,"finding":"In Graves' orbitopathy, exosomal miR-221-5p suppresses CACNG4/AMPK signaling in orbital fibroblasts, driving proinflammatory, profibrotic, and adipogenic phenotypes; partial rescue of these pathogenic phenotypes by miR-221-5p inhibition confirmed the functional centrality of CACNG4 suppression in this pathway.","method":"Exosome isolation and characterization, primary human orbital fibroblast functional assays, miR-221-5p inhibition, in vivo mouse GO model, single-cell RNA sequencing, histopathology, MRI","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — miR-221-5p/CACNG4/AMPK axis supported by inhibitor rescue experiments and in vivo model, single lab, multiple methods","pmids":["42203012"],"is_preprint":false}],"current_model":"CACNG4 encodes a voltage-dependent calcium channel gamma subunit that functions as a channel pore regulator (inhibiting calcium influx when overexpressed), maintains pancreatic beta-cell differentiation via a CaMKII→MafA pathway, suppresses seizures in the thalamus through overlapping function with CACNG2, promotes breast cancer metastasis by altering calcium signaling through AKT2/HDAC3/RASA1/PKCζ, sustains hepatocellular carcinoma stem cells, participates in a CUEDC1/CACNG4/PI3K axis driving glycolysis in ER+ breast cancer, and is suppressed by exosomal miR-221-5p to activate orbital fibroblasts in Graves' orbitopathy."},"narrative":{"mechanistic_narrative":"CACNG4 is a voltage-dependent calcium channel gamma subunit that modulates calcium influx and the downstream signaling driven by it, with roles spanning neuronal excitability, cellular differentiation, and tumor progression [PMID:10613843, PMID:32062352]. It was identified as a member of the calcium channel gamma subunit gene family by synteny to CACNG1 and CACNG2 [PMID:10613843]. In the nervous system it acts within the corticothalamic circuit to suppress seizures, functioning redundantly with CACNG2: Cacng4 knockout mice are phenotypically normal, but combining the null allele with stargazer (Cacng2) mutations induces or worsens absence seizures [PMID:15677329]. CACNG4 maintains the differentiated state of pancreatic beta-cells, where its deletion blunts glucose-stimulated insulin secretion and reduces the transcription factor MafA through a CaMKII-dependent pathway [PMID:35453520]. In cancer, CACNG4 promotes breast cancer metastasis by closing the channel pore to limit calcium influx and reroute survival and metastatic signaling through effectors including AKT2, HDAC3, RASA1, and PKCζ [PMID:32062352], participates in a CUEDC1/CACNG4/PI3K axis that drives glycolysis and tumor growth in ER-positive breast cancer [PMID:41315933], and sustains hepatocellular carcinoma cancer stem cells [PMID:37909988].","teleology":[{"year":1999,"claim":"Established CACNG4 as a distinct gene within the calcium channel gamma subunit family, placing it in a defined molecular context.","evidence":"Low-stringency genomic sequence analysis and synteny mapping against CACNG1/CACNG2","pmids":["10613843"],"confidence":"Medium","gaps":["No functional or biochemical characterization of the encoded protein","Channel-modulating activity not yet demonstrated"]},{"year":2002,"claim":"Linked CACNG4 expression to the onset of cellular differentiation, raising the possibility it modulates calcium channels during development.","evidence":"In situ hybridization and developmental expression analysis in chick embryo neurons and myoblasts","pmids":["11884034"],"confidence":"Medium","gaps":["Correlative expression only, no loss-of-function test","Direct channel target not identified"]},{"year":2005,"claim":"Defined an in vivo neuronal role by showing CACNG4 suppresses seizures redundantly with CACNG2 in the corticothalamic loop.","evidence":"Cacng4 knockout mouse with genetic epistasis against multiple stargazer (Cacng2) alleles, seizure phenotyping, expression localization","pmids":["15677329"],"confidence":"High","gaps":["Specific channels regulated in thalamus not identified","Molecular basis of overlap with CACNG2 unresolved"]},{"year":2020,"claim":"Demonstrated that CACNG4 drives breast cancer metastasis by inhibiting calcium influx and rewiring survival/metastatic signaling.","evidence":"Gain/loss-of-function in 2D/3D culture, calcium influx assays, chick-CAM and mouse metastasis models, downstream effector profiling (AKT2/HDAC3/RASA1/PKCζ)","pmids":["32062352"],"confidence":"High","gaps":["Direct physical link between CACNG4 and each effector not established","Channel pore-closing mechanism inferred pharmacologically"]},{"year":2022,"claim":"Showed CACNG4 maintains pancreatic beta-cell identity via a CaMKII→MafA pathway, extending its role to endocrine homeostasis.","evidence":"Cacng4 knockout mouse metabolic phenotyping, mRNA/protein analysis, CaMKII pathway dissection, validation in human islets and INS-1 cells","pmids":["35453520"],"confidence":"High","gaps":["How CACNG4-modulated calcium signal activates CaMKII not detailed","Channel partner subunits in beta-cells unidentified"]},{"year":2023,"claim":"Implicated CACNG4 in maintaining the cancer stem cell state in hepatocellular carcinoma.","evidence":"ALDH1A1-high cell sorting, microarray, tumorsphere assays, amlodipine inhibition cytotoxicity","pmids":["37909988"],"confidence":"Medium","gaps":["Amlodipine is not CACNG4-specific","Downstream signaling in CSCs not defined"]},{"year":2025,"claim":"Positioned CACNG4 within a CUEDC1/CACNG4/PI3K axis controlling glycolysis in ER-positive breast cancer.","evidence":"RNA-seq, ChIP, dual-luciferase reporter, glycolysis assays, xenograft model","pmids":["41315933"],"confidence":"Medium","gaps":["Mechanism by which CUEDC1 modulates CACNG4 not biochemically resolved","Relationship to calcium influx in this context unclear"]},{"year":2026,"claim":"Identified CACNG4 suppression as a node downstream of exosomal miR-221-5p driving orbital fibroblast pathology in Graves' orbitopathy.","evidence":"Exosome characterization, primary fibroblast assays, miR-221-5p inhibition rescue, in vivo GO model, scRNA-seq","pmids":["42203012"],"confidence":"Medium","gaps":["Direct miR-221-5p binding to CACNG4 transcript not detailed","Link between CACNG4 and AMPK signaling mechanistically thin"]},{"year":null,"claim":"How CACNG4's channel-modulating activity is mechanistically coupled to the diverse downstream pathways (CaMKII, AKT2/PI3K, AMPK) across tissues remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of CACNG4-channel interaction in the timeline","Whether pore modulation is the common mechanism across all contexts is untested","Direct physical partners of CACNG4 not biochemically defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3]}],"localization":[],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4]}],"complexes":[],"partners":["CACNG2","CUEDC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBN1","full_name":"Voltage-dependent calcium channel gamma-4 subunit","aliases":["Neuronal voltage-gated calcium channel gamma-4 subunit","Transmembrane AMPAR regulatory protein gamma-4","TARP gamma-4"],"length_aa":327,"mass_kda":36.6,"function":"Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit (PubMed:21127204). Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs), including GRIA1 and GRIA4. Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization (PubMed:21172611)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9UBN1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CACNG4","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CACNG4","total_profiled":1310},"omim":[{"mim_id":"606900","title":"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8","url":"https://www.omim.org/entry/606900"},{"mim_id":"606405","title":"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT; CACNG5","url":"https://www.omim.org/entry/606405"},{"mim_id":"606404","title":"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT; CACNG4","url":"https://www.omim.org/entry/606404"},{"mim_id":"606403","title":"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3","url":"https://www.omim.org/entry/606403"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":58.1}],"url":"https://www.proteinatlas.org/search/CACNG4"},"hgnc":{"alias_symbol":["MGC11138","MGC24983"],"prev_symbol":[]},"alphafold":{"accession":"Q9UBN1","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBN1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBN1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBN1-F1-predicted_aligned_error_v6.png","plddt_mean":66.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CACNG4","jax_strain_url":"https://www.jax.org/strain/search?query=CACNG4"},"sequence":{"accession":"Q9UBN1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBN1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBN1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBN1"}},"corpus_meta":[{"pmid":"10613843","id":"PMC_10613843","title":"Identification of three novel Ca(2+) channel gamma subunit genes reveals molecular diversification by tandem and chromosome duplication.","date":"1999","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/10613843","citation_count":55,"is_preprint":false},{"pmid":"27102562","id":"PMC_27102562","title":"Evaluation of voltage-dependent calcium channel γ gene families identified several novel potential susceptible genes to schizophrenia.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27102562","citation_count":54,"is_preprint":false},{"pmid":"19301967","id":"PMC_19301967","title":"Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation.","date":"2009","source":"Journal of neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/19301967","citation_count":44,"is_preprint":false},{"pmid":"32062352","id":"PMC_32062352","title":"Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/32062352","citation_count":34,"is_preprint":false},{"pmid":"15677329","id":"PMC_15677329","title":"A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15677329","citation_count":30,"is_preprint":false},{"pmid":"27602771","id":"PMC_27602771","title":"Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27602771","citation_count":25,"is_preprint":false},{"pmid":"11884034","id":"PMC_11884034","title":"Identification and characterization of a calcium channel gamma subunit expressed in differentiating neurons and myoblasts.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11884034","citation_count":23,"is_preprint":false},{"pmid":"27096430","id":"PMC_27096430","title":"Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin-Induced Diabetic Rat.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27096430","citation_count":22,"is_preprint":false},{"pmid":"34349225","id":"PMC_34349225","title":"Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34349225","citation_count":21,"is_preprint":false},{"pmid":"30246030","id":"PMC_30246030","title":"The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.","date":"2018","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/30246030","citation_count":20,"is_preprint":false},{"pmid":"36569910","id":"PMC_36569910","title":"Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36569910","citation_count":18,"is_preprint":false},{"pmid":"17936981","id":"PMC_17936981","title":"[Novel methylation and expression markers associated with breast cancer].","date":"2007","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/17936981","citation_count":17,"is_preprint":false},{"pmid":"32822435","id":"PMC_32822435","title":"Novel genes involved in the genetic architecture of temperament in Brahman cattle.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32822435","citation_count":16,"is_preprint":false},{"pmid":"27746059","id":"PMC_27746059","title":"Identification of Transcription Factor-Gene Regulatory Network in Acute Myocardial Infarction.","date":"2016","source":"Heart, lung & circulation","url":"https://pubmed.ncbi.nlm.nih.gov/27746059","citation_count":16,"is_preprint":false},{"pmid":"34557425","id":"PMC_34557425","title":"Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34557425","citation_count":15,"is_preprint":false},{"pmid":"29351810","id":"PMC_29351810","title":"Identify Down syndrome transcriptome associations using integrative analysis of microarray database and correlation-interaction network.","date":"2018","source":"Human genomics","url":"https://pubmed.ncbi.nlm.nih.gov/29351810","citation_count":15,"is_preprint":false},{"pmid":"30136073","id":"PMC_30136073","title":"Dominance effects of ion transport and ion transport regulator genes on the final weight and backfat thickness of Landrace pigs by dominance deviation analysis.","date":"2018","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30136073","citation_count":13,"is_preprint":false},{"pmid":"34607975","id":"PMC_34607975","title":"Transcriptome study of oleanolic acid in the inhibition of breast tumor growth based on high-throughput sequencing.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34607975","citation_count":12,"is_preprint":false},{"pmid":"24038377","id":"PMC_24038377","title":"Transforming growth factor-β1 primes proliferating adult neural progenitor cells to electrophysiological functionality.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/24038377","citation_count":9,"is_preprint":false},{"pmid":"31375088","id":"PMC_31375088","title":"Exploring the molecular basis of neuronal excitability in a vocal learner.","date":"2019","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31375088","citation_count":8,"is_preprint":false},{"pmid":"17295603","id":"PMC_17295603","title":"Quantitative trait locus that determines the cross-sectional shape of the femur in SAMP6 and SAMP2 mice.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17295603","citation_count":7,"is_preprint":false},{"pmid":"37909988","id":"PMC_37909988","title":"Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine.","date":"2023","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37909988","citation_count":5,"is_preprint":false},{"pmid":"39508990","id":"PMC_39508990","title":"Multi-Omics Approach Reveals Genes and Pathways Affected in Miller-Dieker Syndrome.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39508990","citation_count":4,"is_preprint":false},{"pmid":"39031522","id":"PMC_39031522","title":"Rare and common variants associated with alcohol consumption identify a conserved molecular network.","date":"2024","source":"Alcohol, clinical & experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/39031522","citation_count":4,"is_preprint":false},{"pmid":"35453520","id":"PMC_35453520","title":"The Calcium Channel Subunit Gamma-4 as a Novel Regulator of MafA in Pancreatic Beta-Cell Controls Glucose Homeostasis.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35453520","citation_count":4,"is_preprint":false},{"pmid":"36941576","id":"PMC_36941576","title":"Transcriptomic profiles of the ruminal wall in Italian Mediterranean dairy buffaloes fed green forage.","date":"2023","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/36941576","citation_count":2,"is_preprint":false},{"pmid":"41315933","id":"PMC_41315933","title":"CUEDC1 promotes glycolytic metabolism reprogramming through the CUEDC1/CACNG4/PI3K axis to promote ER-positive breast cancer growth.","date":"2025","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/41315933","citation_count":1,"is_preprint":false},{"pmid":"37239364","id":"PMC_37239364","title":"Genetic Variants and Their Putative Effects on microRNA-Seed Sites: Characterization of the 3' Untranslated Region of Genes Associated with Temperament.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37239364","citation_count":1,"is_preprint":false},{"pmid":"37747033","id":"PMC_37747033","title":"Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer.","date":"2023","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37747033","citation_count":1,"is_preprint":false},{"pmid":"38464225","id":"PMC_38464225","title":"Rare and Common Variants Associated with Alcohol Consumption Identify a Conserved Molecular Network.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38464225","citation_count":1,"is_preprint":false},{"pmid":"39676131","id":"PMC_39676131","title":"Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation.","date":"2024","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39676131","citation_count":0,"is_preprint":false},{"pmid":"42203012","id":"PMC_42203012","title":"Plasma-derived exosomes from Graves' orbitopathy: Pathogenic entities causing tissue lesions.","date":"2026","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/42203012","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.22.24312447","title":"Unveiling Genetic Associations: Investigating<i>CLDN16, GRID2, NRG3,</i>and<i>CACNG4</i>Gene Polymorphisms with Insulin Resistance Risk Among Normal BMI Individuals in the Indian Population","date":"2024-08-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.22.24312447","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20764,"output_tokens":2229,"usd":0.047864,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9358,"output_tokens":2498,"usd":0.05462,"stage2_stop_reason":"end_turn"},"total_usd":0.102484,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"CACNG4 was identified as a novel calcium channel gamma subunit gene located on chromosome 17, discovered through low-stringency genomic sequence analysis of regions syntenic to CACNG1 and CACNG2, establishing it as a member of the voltage-dependent Ca2+ channel gamma subunit gene family generated by tandem and chromosome duplication.\",\n      \"method\": \"Genomic sequence analysis, gene family identification by synteny\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene identification with genomic and evolutionary analysis, single study but clear experimental basis\",\n      \"pmids\": [\"10613843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CACNG4 has seizure-suppressing activity in the corticothalamic circuit; homozygous Cacng4 knockout mice appear phenotypically normal, but combining the Cacng4 null allele with stargazer (Cacng2) mutant alleles exacerbates or induces absence seizures, demonstrating overlapping in vivo functions between CACNG4 and CACNG2 and restricting CACNG4 expression to the thalamus within the corticothalamic loop.\",\n      \"method\": \"Targeted gene disruption (knockout mouse), genetic epistasis (double mutant with Cacng2 alleles), seizure phenotype analysis, expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with defined phenotype, genetic epistasis with multiple Cacng2 alleles, expression localization, single rigorous study with multiple orthogonal approaches\",\n      \"pmids\": [\"15677329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Chick CACNG4 is expressed in differentiating neurons and myoblasts during early development, with expression timing correlating precisely with the onset of neuronal differentiation in cranial and dorsal root ganglia and in the myotome, suggesting a role in modulating calcium channels during cellular differentiation.\",\n      \"method\": \"In situ hybridization, developmental expression analysis in chick embryo\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — expression characterization in developing tissue with functional inference, single lab, replicated across multiple tissue types\",\n      \"pmids\": [\"11884034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CACNG4 promotes breast cancer metastasis by closing the channel pore to inhibit calcium influx, thereby altering calcium signaling through key survival and metastatic pathway genes including AKT2, HDAC3, RASA1, and PKCζ; CACNG4 overexpression alters cell motility in vitro, induces malignant transformation in 3D culture, and increases lung-specific metastasis in vivo.\",\n      \"method\": \"In vitro 2D and 3D assays, intracellular calcium influx assays, chick-CAM model, mouse metastasis model, gain/loss-of-function experiments, calcium channel blocker treatment\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo assays, direct calcium influx measurement, identification of downstream effectors, single lab with rigorous functional validation\",\n      \"pmids\": [\"32062352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CACNG4 (CaVγ4) is required for pancreatic beta-cell maintenance of its differentiated state; Cacng4 knockout mice exhibit impaired fasting glucose and impaired glucose tolerance with blunted glucose-stimulated insulin secretion. CaVγ4 deletion reduces expression of the transcription factor MafA (on mRNA and protein levels), and CaMKII mediates the regulatory pathway linking CaVγ4 to MafA, as confirmed in mouse islets, human donor islets, and INS-1 832/13 cells.\",\n      \"method\": \"Cacng4 knockout mouse (in vivo glucose tolerance and insulin secretion assays), gene expression analysis (mRNA and protein), CaMKII pathway investigation, human islet RNA-seq validation, INS-1 cell line experiments\",\n      \"journal\": \"Biomedicines\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse with defined metabolic phenotype, mechanistic pathway (CaVγ4→CaMKII→MafA) validated in multiple model systems including human islets\",\n      \"pmids\": [\"35453520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CUEDC1 directly modulates CACNG4 to enhance PI3K/AKT pathway activation, thereby facilitating glycolysis (via GLUT1 upregulation) and tumor growth in ER-positive breast cancer; this CUEDC1/CACNG4/PI3K axis was identified by RNA-seq, ChIP, and dual-luciferase reporter assays, with MAZ transcription factor upregulating CUEDC1 transcription.\",\n      \"method\": \"Dual-luciferase reporter assay, RNA-seq, chromatin immunoprecipitation (ChIP), metabolic glycolysis assays, mouse xenograft model, western blotting, qRT-PCR\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal molecular methods in single lab, mechanistic pathway defined with functional readouts in vitro and in vivo\",\n      \"pmids\": [\"41315933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CACNG4 is upregulated in cancer stem cells (CSCs) of hepatocellular carcinoma (HCC); pharmacological inhibition of CACNG4 with amlodipine at low concentrations preferentially reduced CSC viability, markedly decreased tumorsphere formation, and reduced the ALDH1A1-high cell population, indicating a role for CACNG4 in maintaining the CSC state.\",\n      \"method\": \"FACS sorting of ALDH1A1-high cells, microarray gene expression analysis, tumorsphere formation assay, cytotoxicity assay with amlodipine (CACNG4 inhibitor)\",\n      \"journal\": \"Anticancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological inhibition with functional readouts, single lab, limited mechanistic depth but multiple functional assays\",\n      \"pmids\": [\"37909988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In Graves' orbitopathy, exosomal miR-221-5p suppresses CACNG4/AMPK signaling in orbital fibroblasts, driving proinflammatory, profibrotic, and adipogenic phenotypes; partial rescue of these pathogenic phenotypes by miR-221-5p inhibition confirmed the functional centrality of CACNG4 suppression in this pathway.\",\n      \"method\": \"Exosome isolation and characterization, primary human orbital fibroblast functional assays, miR-221-5p inhibition, in vivo mouse GO model, single-cell RNA sequencing, histopathology, MRI\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — miR-221-5p/CACNG4/AMPK axis supported by inhibitor rescue experiments and in vivo model, single lab, multiple methods\",\n      \"pmids\": [\"42203012\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CACNG4 encodes a voltage-dependent calcium channel gamma subunit that functions as a channel pore regulator (inhibiting calcium influx when overexpressed), maintains pancreatic beta-cell differentiation via a CaMKII→MafA pathway, suppresses seizures in the thalamus through overlapping function with CACNG2, promotes breast cancer metastasis by altering calcium signaling through AKT2/HDAC3/RASA1/PKCζ, sustains hepatocellular carcinoma stem cells, participates in a CUEDC1/CACNG4/PI3K axis driving glycolysis in ER+ breast cancer, and is suppressed by exosomal miR-221-5p to activate orbital fibroblasts in Graves' orbitopathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CACNG4 is a voltage-dependent calcium channel gamma subunit that modulates calcium influx and the downstream signaling driven by it, with roles spanning neuronal excitability, cellular differentiation, and tumor progression [#0, #3]. It was identified as a member of the calcium channel gamma subunit gene family by synteny to CACNG1 and CACNG2 [#0]. In the nervous system it acts within the corticothalamic circuit to suppress seizures, functioning redundantly with CACNG2: Cacng4 knockout mice are phenotypically normal, but combining the null allele with stargazer (Cacng2) mutations induces or worsens absence seizures [#1]. CACNG4 maintains the differentiated state of pancreatic beta-cells, where its deletion blunts glucose-stimulated insulin secretion and reduces the transcription factor MafA through a CaMKII-dependent pathway [#4]. In cancer, CACNG4 promotes breast cancer metastasis by closing the channel pore to limit calcium influx and reroute survival and metastatic signaling through effectors including AKT2, HDAC3, RASA1, and PKCζ [#3], participates in a CUEDC1/CACNG4/PI3K axis that drives glycolysis and tumor growth in ER-positive breast cancer [#5], and sustains hepatocellular carcinoma cancer stem cells [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established CACNG4 as a distinct gene within the calcium channel gamma subunit family, placing it in a defined molecular context.\",\n      \"evidence\": \"Low-stringency genomic sequence analysis and synteny mapping against CACNG1/CACNG2\",\n      \"pmids\": [\"10613843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or biochemical characterization of the encoded protein\", \"Channel-modulating activity not yet demonstrated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked CACNG4 expression to the onset of cellular differentiation, raising the possibility it modulates calcium channels during development.\",\n      \"evidence\": \"In situ hybridization and developmental expression analysis in chick embryo neurons and myoblasts\",\n      \"pmids\": [\"11884034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative expression only, no loss-of-function test\", \"Direct channel target not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined an in vivo neuronal role by showing CACNG4 suppresses seizures redundantly with CACNG2 in the corticothalamic loop.\",\n      \"evidence\": \"Cacng4 knockout mouse with genetic epistasis against multiple stargazer (Cacng2) alleles, seizure phenotyping, expression localization\",\n      \"pmids\": [\"15677329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific channels regulated in thalamus not identified\", \"Molecular basis of overlap with CACNG2 unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that CACNG4 drives breast cancer metastasis by inhibiting calcium influx and rewiring survival/metastatic signaling.\",\n      \"evidence\": \"Gain/loss-of-function in 2D/3D culture, calcium influx assays, chick-CAM and mouse metastasis models, downstream effector profiling (AKT2/HDAC3/RASA1/PKCζ)\",\n      \"pmids\": [\"32062352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical link between CACNG4 and each effector not established\", \"Channel pore-closing mechanism inferred pharmacologically\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed CACNG4 maintains pancreatic beta-cell identity via a CaMKII→MafA pathway, extending its role to endocrine homeostasis.\",\n      \"evidence\": \"Cacng4 knockout mouse metabolic phenotyping, mRNA/protein analysis, CaMKII pathway dissection, validation in human islets and INS-1 cells\",\n      \"pmids\": [\"35453520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CACNG4-modulated calcium signal activates CaMKII not detailed\", \"Channel partner subunits in beta-cells unidentified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated CACNG4 in maintaining the cancer stem cell state in hepatocellular carcinoma.\",\n      \"evidence\": \"ALDH1A1-high cell sorting, microarray, tumorsphere assays, amlodipine inhibition cytotoxicity\",\n      \"pmids\": [\"37909988\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Amlodipine is not CACNG4-specific\", \"Downstream signaling in CSCs not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Positioned CACNG4 within a CUEDC1/CACNG4/PI3K axis controlling glycolysis in ER-positive breast cancer.\",\n      \"evidence\": \"RNA-seq, ChIP, dual-luciferase reporter, glycolysis assays, xenograft model\",\n      \"pmids\": [\"41315933\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which CUEDC1 modulates CACNG4 not biochemically resolved\", \"Relationship to calcium influx in this context unclear\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified CACNG4 suppression as a node downstream of exosomal miR-221-5p driving orbital fibroblast pathology in Graves' orbitopathy.\",\n      \"evidence\": \"Exosome characterization, primary fibroblast assays, miR-221-5p inhibition rescue, in vivo GO model, scRNA-seq\",\n      \"pmids\": [\"42203012\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct miR-221-5p binding to CACNG4 transcript not detailed\", \"Link between CACNG4 and AMPK signaling mechanistically thin\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CACNG4's channel-modulating activity is mechanistically coupled to the diverse downstream pathways (CaMKII, AKT2/PI3K, AMPK) across tissues remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of CACNG4-channel interaction in the timeline\", \"Whether pore modulation is the common mechanism across all contexts is untested\", \"Direct physical partners of CACNG4 not biochemically defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CACNG2\", \"CUEDC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}